Ivermectin in Covid 19 Patients a Multicenter, Retrospective Study
*Corresponding Author:Received Date: Aug 02, 2021 / Accepted Date: Aug 22, 2022 / Published Date: Aug 29, 2022
Copyright: © 2022 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
During 2020, many Medical Centers and solo Practitioners have adopted the I.D.E.A. protocol (ivermectin, Dexamethasone, Enoxaparin and Aspirin) as the only inexpensive, effective, safe means to fight COVID infection.We hereby summarize the experience of some of these endeavours, stressing the fact that -by providing their patients with this protocol- they have saved thousands of lives that, if not, would have been put in an unecessary danger, or simple lost. We take into consideration the percentage of COVID + patients that required ulterior admittance, and also the death rate amid those admitted.